SCHEMBL7347199

SCHEMBL7347199

CC(C)=C1Oc2cccc(OCc3ccccc3CCl)c2C1=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.33
MAOA P21397 1/20 0.33
FABP4 P15090 3/20 0.33
FABP5 Q01469 3/20 0.33
STK17B O94768 1/20 0.33
TP53 P04637 1/20 0.33
HTT P42858 1/20 0.33
LTB4R Q15722 1/20 0.32
LTB4R2 Q9NPC1 1/20 0.32
CDK4 P11802 1/20 0.32
CCND1 P24385 1/20 0.32
PRKCA P17252 1/20 0.31
NPC1 O15118 1/20 0.31
ABCB1 P08183 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.31
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7353733 0.84 MAOB (0.43) MAOBMAOASTK17BLTB4RLTB4R2
SCHEMBL7346833 0.82 MAOB (0.37) MAOBMAOASTK17BTP53LTB4R
SCHEMBL7346994 0.81 TXNRD1 (0.34) MAOBMAOASTK17B
SCHEMBL6422310 0.81 MTNR1A (0.36) MAOBMAOASTK17BTP53PRKCA
SCHEMBL6426238 0.80 KCNA3 (0.37) MAOBMAOASTK17BPRKCAMAPT
SCHEMBL7347057 0.77 STK17B (0.33) STK17BMEN1KMT2ATHRB
SCHEMBL6824170 0.74 LMNA (0.47) STK17BLTB4RLTB4R2PRKCAMEN1
SCHEMBL6820565 0.74 KCNA3 (0.36) MAOBMAOASTK17BPRKCAMAPT
SCHEMBL6820552 0.71 STK17B (0.35) MAOBMAOASTK17BHTTPRKCA
SCHEMBL6826208 0.70 F2RL3 (0.41) STK17BPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6307051-B1 UROKINASE-TYPE PLASMINOGEN ACTIVATOR ANTAGONISTS AND HAVE ANTITUMOR AND ANTIMETASTATIC ACTIVITY. ROCHE DIAGNOSTICS GMBH (DE) 2001-10-23 US disclosed
EP-1026165-A1 O-substituted Hydroxycoumaranone derivatives as antitumor and antimetastatic agents Roche Diagnostics GmbH (DE) 2000-08-09 EP disclosed